{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:40:57Z","timestamp":1761986457631},"reference-count":32,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.prostaglandins.2010.03.003","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T06:04:59Z","timestamp":1271052299000},"page":"73-76","source":"Crossref","is-referenced-by-count":40,"title":["Increased leukotriene E4 excretion in systemic mastocytosis"],"prefix":"10.1016","volume":"92","author":[{"given":"Joseph H.","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (4)","key":"10.1016\/j.prostaglandins.2010.03.003_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2007.09.004","article-title":"Urinary leukotriene E4","volume":"27","author":"Rabinovitch","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"issue":"September (5)","key":"10.1016\/j.prostaglandins.2010.03.003_bib2","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.177.5.2755","article-title":"Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine\/intracrine cysteinyl leukotriene-induced signaling","volume":"177","author":"Jiang","year":"2006","journal-title":"J Immunol"},{"issue":"June (24)","key":"10.1016\/j.prostaglandins.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1074\/jbc.M705822200","article-title":"Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells","volume":"283","author":"Paruchuri","year":"2008","journal-title":"J Biol Chem"},{"issue":"June (6738)","key":"10.1016\/j.prostaglandins.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"issue":"September (39)","key":"10.1016\/j.prostaglandins.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J Biol Chem"},{"issue":"August (2)","key":"10.1016\/j.prostaglandins.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1183\/09031936.00093407","article-title":"Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia","volume":"32","author":"Ono","year":"2008","journal-title":"Eur Respir J"},{"issue":"August (5)","key":"10.1016\/j.prostaglandins.2010.03.003_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1399-3038.2005.00294.x","article-title":"Urine leukotriene E and eosinophil cationic protein in nasopharyngeal aspiration from young wheezy children","volume":"16","author":"Oh","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2010.03.003_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2133.2001.03947.x","article-title":"Increased urinary leukotriene E4 excretion in patients with atopic dermatitis","volume":"144","author":"Hishinuma","year":"2001","journal-title":"Br J Dermatol"},{"issue":"May (4)","key":"10.1016\/j.prostaglandins.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00005176-199505000-00005","article-title":"Levels of peptidoleukotriene E4 are elevated in active Crohn's disease","volume":"20","author":"Kim","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"November\u2013December (5\u20136)","key":"10.1016\/j.prostaglandins.2010.03.003_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1054\/plef.2001.0329","article-title":"Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis","volume":"65","author":"Nakamura","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.85.1.230","article-title":"Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation","volume":"85","author":"Carry","year":"1992","journal-title":"Circulation"},{"issue":"October (10)","key":"10.1016\/j.prostaglandins.2010.03.003_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00019501-199310000-00009","article-title":"Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery","volume":"4","author":"Allen","year":"1993","journal-title":"Coron Artery Dis"},{"issue":"January (1 Pt 1)","key":"10.1016\/j.prostaglandins.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0091-6749(94)90238-0","article-title":"Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease","volume":"93","author":"Greally","year":"1994","journal-title":"J Allergy Clin Immunol"},{"issue":"November (18)","key":"10.1016\/j.prostaglandins.2010.03.003_bib14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"issue":"December (6660)","key":"10.1016\/j.prostaglandins.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/37622","article-title":"Role of cytosolic phospholipase A2 in allergic response and parturition","volume":"390","author":"Uozumi","year":"1997","journal-title":"Nature"},{"issue":"October (40)","key":"10.1016\/j.prostaglandins.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"41512","DOI":"10.1074\/jbc.M312568200","article-title":"Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523","volume":"279","author":"Luo","year":"2004","journal-title":"J Biol Chem"},{"issue":"October (5)","key":"10.1016\/j.prostaglandins.2010.03.003_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization","volume":"17","author":"Valent","year":"2003","journal-title":"Hematol Oncol Clin N Am"},{"issue":"August (3)","key":"10.1016\/j.prostaglandins.2010.03.003_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.iac.2006.05.006","article-title":"Systemic mastocytosis: clinical manifestations and differential diagnosis","volume":"26","author":"Butterfield","year":"2006","journal-title":"Immunol Allergy Clin N Am"},{"issue":"August (3)","key":"10.1016\/j.prostaglandins.2010.03.003_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.iac.2006.05.005","article-title":"Mast cell mediators in allergic inflammation and mastocytosis","volume":"26","author":"Castells","year":"2006","journal-title":"Immunol Allergy Clin N Am"},{"issue":"June (6)","key":"10.1016\/j.prostaglandins.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","article-title":"Urinary leukotriene E4 in bronchial asthma","volume":"5","author":"Smith","year":"1992","journal-title":"Eur Respir J"},{"issue":"March (8638)","key":"10.1016\/j.prostaglandins.2010.03.003_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(89)91611-5","article-title":"Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis","volume":"1","author":"Taylor","year":"1989","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/0929867306666220207211259","article-title":"5-Lipoxygenase: a target for antiinflammatory drugs revisited","volume":"6","author":"Steinhilber","year":"1999","journal-title":"Curr Med Chem"},{"issue":"February (2 Pt 2)","key":"10.1016\/j.prostaglandins.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-20","article-title":"Measurement of leukotrienes in humans","volume":"161","author":"Kumlin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"April (4)","key":"10.1016\/j.prostaglandins.2010.03.003_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","article-title":"Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"Autumn (4)","key":"10.1016\/j.prostaglandins.2010.03.003_bib25","first-page":"379","article-title":"Advances in therapy with antileukotriene drugs","volume":"34","author":"Riccioni","year":"2004","journal-title":"Ann Clin Lab Sci"},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2010.03.003_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2010.03.003_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mai.2003.67","article-title":"Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma","volume":"111","author":"Steinke","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2010.03.003_bib28","first-page":"1","article-title":"The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists","volume":"9","author":"Rackal","year":"2004","journal-title":"Skin Therapy Lett"},{"issue":"October (4)","key":"10.1016\/j.prostaglandins.2010.03.003_bib29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1378\/chest.122.4.1497","article-title":"Irritable bowel syndrome helped by montelukast","volume":"122","author":"Fee","year":"2002","journal-title":"Chest"},{"issue":"February (7)","key":"10.1016\/j.prostaglandins.2010.03.003_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM200402123500723","article-title":"Leukotriene-receptor inhibition for the treatment of systemic mastocytosis","volume":"350","author":"Tolar","year":"2004","journal-title":"N Engl J Med"},{"issue":"June (6 Suppl. 1)","key":"10.1016\/j.prostaglandins.2010.03.003_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(01)01129-3","article-title":"Mast cell involvement in interstitial cystitis: a review of human and experimental evidence","volume":"57","author":"Theoharides","year":"2001","journal-title":"Urology"},{"issue":"November (5)","key":"10.1016\/j.prostaglandins.2010.03.003_bib32","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0022-5347(05)65663-7","article-title":"The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis","volume":"166","author":"Bouchelouche","year":"2001","journal-title":"J Urol"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:25:12Z","timestamp":1685561112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882310000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":32,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1098882310000377"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2010.03.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}